Doctors are concerned that a Supreme Court ruling issued June 29 will have far-reaching effects not only on the diversity of doctors and other care providers in training but ultimately also on patient care.
As India grows its biologics market, Aragen builds new $30M facility
Aragen Life Sciences is launching a new $30 million biologics manufacturing site in Bangalore due to growing demand, the India-based drug manufacturer said Monday. The